Singapore markets closed

argenx SE (ARGX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
393.49+13.48 (+3.55%)
At close: 04:00PM EST
393.85 +0.36 (+0.09%)
After hours: 04:42PM EST
Full screen
Trade prices are not sourced from all markets
Previous close380.01
Open379.87
Bid350.00 x 800
Ask398.00 x 900
Day's range379.50 - 394.10
52-week range327.73 - 550.76
Volume427,434
Avg. volume485,263
Market cap23.335B
Beta (5Y monthly)0.38
PE ratio (TTM)N/A
EPS (TTM)-4.09
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est471.10
  • Insider Monkey

    argenx SE (NASDAQ:ARGX) Q4 2023 Earnings Call Transcript

    argenx SE (NASDAQ:ARGX) Q4 2023 Earnings Call Transcript February 29, 2024 argenx SE misses on earnings expectations. Reported EPS is $-1.68 EPS, expectations were $-1.23. ARGX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name is Rob, […]

  • GlobeNewswire

    argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update

    $374 million in fourth quarter and $1.2 billion in full year global net product sales sBLA for VYVGART® Hytrulo for CIDP accepted for priority review by FDA with PDUFA target action date of June 21, 2024 On track to report data from six Phase 2 proof-of-concept trials by end of 2024 Management to host conference call today at 2:30 pm CET (8:30 am ET) February 29, 2024, 7:00 am CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving

  • Zacks

    Is a Surprise Coming for argenx (ARGX) This Earnings Season?

    argenx (ARGX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.